Canntab Therapeutics Limited
CTABF · OTC
5/31/2022 | 5/31/2021 | 5/31/2020 | 5/31/2019 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$3,689 | -$4,420 | -$2,607 | -$2,459 |
| Dep. & Amort. | $635 | $546 | $296 | $81 |
| Deferred Tax | $0 | $900 | $0 | $0 |
| Stock-Based Comp. | $450 | $633 | $415 | $402 |
| Change in WC | -$182 | -$647 | $131 | -$317 |
| Other Non-Cash | -$59 | $138 | -$133 | -$40 |
| Operating Cash Flow | -$2,846 | -$2,849 | -$1,899 | -$2,333 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$30 | -$345 | -$905 | -$318 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $1,175 | $2,325 |
| Other Inv. Act. | $181 | $0 | $0 | $0 |
| Investing Cash Flow | $151 | -$345 | $270 | $2,007 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $1,236 | $1,413 | -$65 | $0 |
| Stock Issued | $659 | $814 | $3,644 | $22 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $659 | $368 | -$272 | $22 |
| Financing Cash Flow | $1,895 | $2,595 | $3,306 | $22 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$800 | -$600 | $1,676 | -$304 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $1,491 | $2,090 | $414 | $718 |
| End Cash | $691 | $1,491 | $2,090 | $414 |
| Free Cash Flow | -$2,934 | -$3,195 | -$2,805 | -$2,651 |